Nitric oxide supplement (DrugBank: Nitric Oxide)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 251 | Urea cycle disorder | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03064048 (ClinicalTrials.gov) | September 15, 2017 | 10/2/2017 | Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD | Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD) | Argininosuccinate Lyase Deficiency;Urea Cycle Disorder;Urea Cycle Disorders, Inborn;Argininosuccinic Aciduria | Dietary Supplement: Neo-ASA;Dietary Supplement: Placebo | Baylor College of Medicine | Rare Diseases Clinical Research Network;Neogenis Laboratories | Recruiting | 6 Years | 50 Years | All | 16 | N/A | United States |
| 2 | NCT02252770 (ClinicalTrials.gov) | September 2014 | 25/9/2014 | Nitric Oxide Supplementation in Argininosuccinic Aciduria | Nitric Oxide Supplementation as a Therapeutic Intervention in Argininosuccinic Aciduria | Argininosuccinic Aciduria;Argininosuccinate Lyase Deficiency;Urea Cycle Disorders | Dietary Supplement: Nitric oxide supplement;Dietary Supplement: Placebo | Baylor College of Medicine | NULL | Completed | 8 Years | 64 Years | All | 12 | N/A | United States |